Sartorius Stedim BiotechSDMHF +2.46%80 Dividend Yield % is 0.42% as of Jun. 24, 2026, which is 5% above its 10-year median of 0.40. GuruFocus rates SDMHF with a GF Score™ of 80/100 and a GF Value™ of $239.66 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 327 Medical Devices & Instruments companies, Sartorius Stedim Biotech ranks worse than 89.91% on this metric.
As of today (2026-06-24), the Trailing Annual Dividend Yield of Sartorius Stedim Biotech is 0.42%.
Good Sign:
Sartorius Stedim Biotech SA stock Dividend Yield % is close to 1-year high.
The historical rank and industry rank for Sartorius Stedim Biotech's Dividend Yield % or its related term are showing as below:
SDMHF'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.08 Med: 0.4 Max: 0.96
Current: 0.42
During the past 13 years, the highest Dividend Yield of Sartorius Stedim Biotech was 0.96%. The lowest was 0.08%. And the median was 0.40%.
SDMHF's Dividend Yield % is ranked worse than 89.91% of 327
companies
in the Medical Devices & Instruments industry
Industry Median: 1.98
vs SDMHF: 0.42
During the past 3 years, the average Dividends Per Share Growth Rate was -18.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 11.20% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 14.20% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sartorius Stedim Biotech was 63.20% per year. The lowest was -18.20% per year. And the median was 20.85% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SDMHF vs ISRG, BDX, MDLN: Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sartorius Stedim Biotech Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sartorius Stedim Biotech's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Sartorius Stedim Biotech Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
EUR 0.690000
2026-03-31
2026-04-01
2026-04-02
Cash Dividend
annually
EUR:USD 1.156069
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sartorius Stedim Biotech (SDMHF) has a Dividend Yield % of 0.42% as of Jun. 24, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Sartorius Stedim Biotech and its competitors. This is near median its historical median of 0.40. Over the past decade, Sartorius Stedim Biotech's Dividend Yield % has ranged from 0.08 to 0.96. According to the industry distribution chart, Sartorius Stedim Biotech ranks #294 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 89.9%.
Is Sartorius Stedim Biotech's Dividend Yield % too high?
Sartorius Stedim Biotech's current Dividend Yield % of 0.42% is near median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 0.96. The Medical Devices & Instruments industry median Dividend Yield % is 1.98. Sartorius Stedim Biotech's value of 0.42% is 78.8% below this industry median. Based on the distribution chart, Sartorius Stedim Biotech ranks #294 out of 327 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sartorius Stedim Biotech has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius Stedim Biotech's Dividend Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sartorius Stedim Biotech ranks #294 out of 327 companies for Dividend Yield %. This places Sartorius Stedim Biotech in the lower half of its industry. The industry median Dividend Yield % is 1.98. Sartorius Stedim Biotech's value of 0.42% is 78.8% below this benchmark. Historically, Sartorius Stedim Biotech's own Dividend Yield % has ranged from 0.08 to 0.96 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 1.98, Sartorius Stedim Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.98, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sartorius Stedim Biotech's current Dividend Yield % of 0.42% is 78.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Sartorius Stedim Biotech and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sartorius Stedim Biotech's current Dividend Yield % is 0.42%, which is near median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius Stedim Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sartorius Stedim Biotech (SDMHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $239.66, compared to a current price of $190.88 — trading 20.4% below its estimated fair value. The current Dividend Yield % is 0.42%, which is near median its 10-year median of 0.40 and 78.8% below the Medical Devices & Instruments industry median of 1.98. Sartorius Stedim Biotech's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Sartorius Stedim Biotech (SDMHF), the current Dividend Yield % is 0.42% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sartorius Stedim Biotech (SDMHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued.
The current stock price of $190.88 is trading 20.4% below its estimated GF Value™ of $239.66.
GuruFocus considers Sartorius Stedim Biotech to be Modestly Undervalued.
Key valuation signals for SDMHF:
Dividend Yield %: 0.42% (near median its 10-year median of 0.40)
GF Value™: $239.66 vs. price of $190.88 (20.4% below fair value)
Industry Position: 78.8% below the Medical Devices & Instruments median (#294 of 327)
No single metric tells the full story. See the SDMHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
80GF Score
Get the complete analysis for SDMHF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SDMHF has been successfully added to your 
